US Patent Issued to Arizona Board of Regents on behalf of Arizona State University on March 25 for "Methods of treating cancer with TNF expressing myxoma virus" (Arizona, Michigan Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,278, issued on March 25, was assigned to Arizona Board of Regents on behalf of Arizona State University (Scottsdale, Ariz.).

"Methods of treating cancer with TNF expressing myxoma virus" was invented by Douglas Grant McFadden (Tempe, Ariz.), John Christie (Portage, Mich.), Joseph Blattman (Scottsdale, Ariz.), Mohammed Masmudur Rahman (Chandler, Ariz.) and Nancy Yaneth Villa (Scottsdale, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, in certain embodiments, is a method of inhibiting or treating a cancer with use of a TNF expressing myxoma virus. Also disclosed herein are methods of inhibiting or treating a cancer with use of ...